Puma Biotechnology Reports First Quarter 2022 Financial Results | Business Wire
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology (NasdaqGS:PBYI) Stock Price & Quote Analysis - Simply Wall St
Puma Biotechnology
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2022 (History)
PBYI Institutional Ownership and Shareholders - Puma Biotechnology Inc (NASDAQ) Stock
Why Puma Biotechnology Is Soaring Today | The Motley Fool
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology Reports Third Quarter 2021 Financial Results | Business Wire
Puma Biotechnology Inc. | BioWorld
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology
Puma Biotechnology
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Analysts Have Made A Financial Statement On Puma Biotechnology, Inc.'s (NASDAQ:PBYI) First-Quarter Report
Puma Biotechnology Surging
Puma Biotechnology Announces Litigation Victory with Jury's Decision | Business Wire
Puma Biotechnology Inc (PBYI): Hedge Funds Taking Some Chips Off The Table
Articles with Puma Biotechnology
With 53% institutional ownership, Puma Biotechnology, Inc. (NASDAQ:PBYI) is a favorite amongst the big guns | Nasdaq
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2022
PUMA BIOTECHNOLOGY, INC. : PBYI Stock Price | US74587V1070 | MarketScreener
